Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Multiple myeloma. Diagnosis and therapy].

H Goldschmidt1, F W Cremer, T M Möhler

  • 1Medizinische Klinik und Poliklinik V, Universität Heidelberg. Hartmut_Goldschmidt@med.uni-heidelberg.de

Der Internist
|September 12, 2003
PubMed
Summary

Multiple myeloma, a common cancer, requires bone marrow assessment, lab data, and imaging for diagnosis. Advanced therapies like stem cell transplants and new drugs are improving patient survival and prognosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rituximab Chimeric Anti-CD20 Monoclonal Antibody Therapy for Relapsed Indolent Lymphoma: Half of Patients Respond to a Four-Dose Treatment Program.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
Same author

An automated approach to determine antibody endpoint titers for COVID-19 by an enzyme-linked immunosorbent assay.

Immunohematology·2021
Same author

Transplant-associated thrombotic microangiopathy is an endothelial complication associated with refractoriness of acute GvHD.

Bone marrow transplantation·2017
Same author

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma.

BMC cancer·2017
Same author

Molecular signaling in multiple myeloma: association of RAS/RAF mutations and MEK/ERK pathway activation.

Oncogenesis·2017
Same author

GvL effects in T-prolymphocytic leukemia: evidence from MRD kinetics and TCR repertoire analyses.

Bone marrow transplantation·2017

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Context:

  • Multiple myeloma is a frequent malignancy in Germany.
  • Diagnosis relies on bone marrow assessment, laboratory data, and imaging.
  • Molecular cytogenetics enhances understanding of myeloma pathogenesis.

Purpose:

  • To outline diagnostic and prognostic evaluation methods for multiple myeloma.
  • To review current and emerging therapeutic strategies.
  • To highlight advancements in supportive care.

Summary:

  • Cytostatic therapy with alkylating agents and glucocorticoids extends survival.
  • High-dose therapy with autologous hematopoietic stem cell transplantation improves prognosis for eligible patients.
  • Ongoing clinical trials investigate allogeneic stem cell transplant modifications, anti-angiogenic and immunomodulatory drugs, and proteasome inhibitors.

Related Experiment Videos

Impact:

  • Improved understanding of multiple myeloma pathogenesis.
  • Enhanced patient survival through established and novel treatments.
  • Advancements in supportive care, including bisphosphonates, benefit patients.